BioLineRx Appoints Dr. Sandra Panem to Board of Directors

[PR Newswire] – TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today the appointment of Sandra Panem, Ph.D., to its Board of Directors. Dr. Panem h more

View todays social media effects on ACOR

View the latest stocks trending across Twitter. Click to view dashboard

See who Acorda is hiring next, click here to view